Cargando…
The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
Introduction: Smoking has a negative impact on survival of HNSCC patients. In addition, smoking is associated with the prevalence of co-morbidities and, thus, it may be assumed that not smoking per se but co-morbidities impact the course of therapy in terms of lower compliance and dose-reduction. Ho...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105812/ https://www.ncbi.nlm.nih.gov/pubmed/32266158 http://dx.doi.org/10.3389/fonc.2020.00398 |
_version_ | 1783512478868570112 |
---|---|
author | Fazel, Asita Quabius, Elgar Susanne Fabian, Alexander Schleicher, Thilo Kress, Konstantin Laudien, Martin Huber, Karen Herzog, Arved Gonzales Donate, Mireia Hoffmann, Markus |
author_facet | Fazel, Asita Quabius, Elgar Susanne Fabian, Alexander Schleicher, Thilo Kress, Konstantin Laudien, Martin Huber, Karen Herzog, Arved Gonzales Donate, Mireia Hoffmann, Markus |
author_sort | Fazel, Asita |
collection | PubMed |
description | Introduction: Smoking has a negative impact on survival of HNSCC patients. In addition, smoking is associated with the prevalence of co-morbidities and, thus, it may be assumed that not smoking per se but co-morbidities impact the course of therapy in terms of lower compliance and dose-reduction. However, data addressing this issue is sparse and conflicting at present, specifically for HNSCCs. Patients and methods: Patient files and tumor documentation from 643 consecutive cases of the University Head and Neck Cancer Centre Kiel were analyzed retrospectively. Patient characteristics and smoking habits were assessed and correlated with co-morbidities and course of treatment. Results: The examined 643 patient files showed that 113 (17.6%), 349 (54.3%), and 180 (28%) patients were never, active, and former smokers, respectively. Three hundred fifteen (49%) were treated by surgery only; 121 (18.8%) received surgery + adjuvant RCT and 72 (11.2%) surgery + adjuvant RT. 111 (17.3%) received primary RCT and 24 (3.7%) primary RT. 131 (20.4%) and 512 (79.6%) had no or had co-morbidities, respectively. Smoking (>10 py) was significantly associated with co-morbidities (p = 0.002). However, smoking and co-morbidities, neither alone nor in combination, were correlated with failure in reaching target doses of radio(chemo)therapy (p > 0.05). Applying (verified) Carlson-Comorbidity-Index (CCI) did not change the results. Conclusions: As expected, smoking is significantly associated with co-morbidities. Dose-reduction of radio(chemo)therapy is as common among active smokers and patients with co-morbidities as among never smokers and patients without co-morbidities. Thus, smoking and co-morbidity seems to impact survival by other means than impairing planned therapy regimens. |
format | Online Article Text |
id | pubmed-7105812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71058122020-04-07 The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) Fazel, Asita Quabius, Elgar Susanne Fabian, Alexander Schleicher, Thilo Kress, Konstantin Laudien, Martin Huber, Karen Herzog, Arved Gonzales Donate, Mireia Hoffmann, Markus Front Oncol Oncology Introduction: Smoking has a negative impact on survival of HNSCC patients. In addition, smoking is associated with the prevalence of co-morbidities and, thus, it may be assumed that not smoking per se but co-morbidities impact the course of therapy in terms of lower compliance and dose-reduction. However, data addressing this issue is sparse and conflicting at present, specifically for HNSCCs. Patients and methods: Patient files and tumor documentation from 643 consecutive cases of the University Head and Neck Cancer Centre Kiel were analyzed retrospectively. Patient characteristics and smoking habits were assessed and correlated with co-morbidities and course of treatment. Results: The examined 643 patient files showed that 113 (17.6%), 349 (54.3%), and 180 (28%) patients were never, active, and former smokers, respectively. Three hundred fifteen (49%) were treated by surgery only; 121 (18.8%) received surgery + adjuvant RCT and 72 (11.2%) surgery + adjuvant RT. 111 (17.3%) received primary RCT and 24 (3.7%) primary RT. 131 (20.4%) and 512 (79.6%) had no or had co-morbidities, respectively. Smoking (>10 py) was significantly associated with co-morbidities (p = 0.002). However, smoking and co-morbidities, neither alone nor in combination, were correlated with failure in reaching target doses of radio(chemo)therapy (p > 0.05). Applying (verified) Carlson-Comorbidity-Index (CCI) did not change the results. Conclusions: As expected, smoking is significantly associated with co-morbidities. Dose-reduction of radio(chemo)therapy is as common among active smokers and patients with co-morbidities as among never smokers and patients without co-morbidities. Thus, smoking and co-morbidity seems to impact survival by other means than impairing planned therapy regimens. Frontiers Media S.A. 2020-03-24 /pmc/articles/PMC7105812/ /pubmed/32266158 http://dx.doi.org/10.3389/fonc.2020.00398 Text en Copyright © 2020 Fazel, Quabius, Fabian, Schleicher, Kress, Laudien, Huber, Herzog, Gonzales Donate and Hoffmann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Fazel, Asita Quabius, Elgar Susanne Fabian, Alexander Schleicher, Thilo Kress, Konstantin Laudien, Martin Huber, Karen Herzog, Arved Gonzales Donate, Mireia Hoffmann, Markus The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) |
title | The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) |
title_full | The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) |
title_fullStr | The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) |
title_full_unstemmed | The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) |
title_short | The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) |
title_sort | influence of smoking and co-morbidity on dose achievement in primary or adjuvant radio(chemo)therapy in head and neck squamous cell carcinoma (hnscc) |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105812/ https://www.ncbi.nlm.nih.gov/pubmed/32266158 http://dx.doi.org/10.3389/fonc.2020.00398 |
work_keys_str_mv | AT fazelasita theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT quabiuselgarsusanne theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT fabianalexander theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT schleicherthilo theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT kresskonstantin theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT laudienmartin theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT huberkaren theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT herzogarved theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT gonzalesdonatemireia theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT hoffmannmarkus theinfluenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT fazelasita influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT quabiuselgarsusanne influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT fabianalexander influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT schleicherthilo influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT kresskonstantin influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT laudienmartin influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT huberkaren influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT herzogarved influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT gonzalesdonatemireia influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc AT hoffmannmarkus influenceofsmokingandcomorbidityondoseachievementinprimaryoradjuvantradiochemotherapyinheadandnecksquamouscellcarcinomahnscc |